Get the Stockscreener App
0.6424
11.05%
0.0639
After Hours:
.65
0.0076
+1.18%
Inotiv Inc stock is traded at $0.6424, with a volume of 545.88K.
It is up +11.05% in the last 24 hours and down -20.47% over the past month.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
See More
Previous Close:
$0.5785
Open:
$0.596
24h Volume:
545.88K
Relative Volume:
0.73
Market Cap:
$22.08M
Revenue:
$505.30M
Net Income/Loss:
$-78.96M
P/E Ratio:
-0.2386
EPS:
-2.6929
Net Cash Flow:
$-46.37M
1W Performance:
+17.55%
1M Performance:
-20.47%
6M Performance:
-69.26%
1Y Performance:
-88.10%
1-Day Range:
$0.5814
$0.6497
1-Week Range:
$0.5241
$0.6497
52-Week Range:
$0.47
$5.66
Inotiv Inc Stock (NOTV) Company Profile
Name
Inotiv Inc
Sector
Industry
Phone
(317) 463-4527
Address
2701 KENT AVE, WEST LAFAYETTE
Compare NOTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NOTV
Inotiv Inc
|
0.6424 | 19.88M | 505.30M | -78.96M | -46.37M | -2.6929 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Inotiv Inc Stock (NOTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-11-23 | Upgrade | Lake Street | Hold → Buy |
| Nov-18-22 | Downgrade | Lake Street | Buy → Hold |
| Oct-04-22 | Initiated | Jefferies | Buy |
| Jan-31-22 | Initiated | Lake Street | Buy |
| Sep-20-21 | Initiated | Craig Hallum | Buy |
View All
Inotiv Inc Stock (NOTV) Latest News
Book value per share of Inotiv, Inc. – DUS:BS50 - TradingView — Track All Markets
Aug Weekly: nap sao 9029July 2025 Chart Watch & Fast Momentum Entry Tips - moha.gov.vn
Inotiv, Inc. faces business risks amid FDA disruptions and government funding challenges - MSN
Revenue per share of Inotiv, Inc. – DUS:BS50 - TradingView — Track All Markets
Will Inotiv Inc. (BS50) stock extend growth storyJuly 2025 Rallies & Free Fast Entry Momentum Trade Alerts - Улправда
Can Inotiv Inc. (BS50) stock resist broad market declinesBreakout Watch & Verified Momentum Watchlists - Улправда
Why Inotiv Inc. stock could rally in 2025Trade Risk Summary & Technical Pattern Recognition Alerts - Улправда
Will Inotiv Inc. stock rally after Fed decisionsMarket Volume Summary & Stock Timing and Entry Methods - Улправда
Is Inotiv Inc. stock near bottom after declineMarket Activity Recap & Precise Swing Trade Alerts - Улправда
Gains Report: Why Inotiv Inc. stock could rally in 2025Market Trend Summary & Reliable Trade Execution Plans - Улправда
Market Fear: Is Inotiv Inc stock dividend yield sustainable2025 Volume Leaders & Safe Capital Growth Tips - moha.gov.vn
New Highs: Will Alexander Baldwin Inc stock outperform foreign stocksWeekly Risk Report & Fast Gain Swing Alerts - moha.gov.vn
Inotiv partners with Vugene to advance AI-driven drug discovery - MSN
Inotiv, Inc. Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - marketscreener.com
Inotiv partners with VUGENE to enhance AI-assisted drug discovery By Investing.com - Investing.com Canada
Inotiv partners with VUGENE to enhance AI-assisted drug discovery - Investing.com
Inotiv, Inc. and VUGENE Announce Strategic Collaboration to Enhance AI-Assisted Drug Discovery and Data Insights - Quiver Quantitative
Inotiv (NASDAQ: NOTV) and VUGENE align on AI drug discovery, bioinformatics push - Stock Titan
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - Sahm
Inotiv : Investor Presentation December 2025 - marketscreener.com
Cyber CrimeInotiv Confirms Data Breach Exposing Sensitive Employee Information - teiss
NewsInotiv Confirms Data Breach Exposing Sensitive Employee Information - teiss
Drug R&D Firm Facing Costs, Lawsuits in Alleged Qilin Attack - Bank Info Security
Pharmaceutical Firm Inotiv Discloses Ransomware Attack and Data Breach - The HIPAA Journal
Major drug research company confirms cyberattack compromised employee and partner data - Cybersecurity Dive
Full-year loss narrows for Inotiv - Inside INdiana Business
Aug Action: Is Inotiv Inc stock resilient to inflationMarket Trend Report & AI Optimized Trade Strategies - BỘ NỘI VỤ
Inotiv, Inc. reports improved fiscal 2025 results - MSN
Inotiv (NOTV) price target decreased by 12.12% to 4.93 - MSN
Inotiv, Inc. Faces Business Risks Amid FDA Disruptions and Government Funding Challenges - TipRanks
Patterns Watch: Can UWMC stock beat market expectations this quarter2025 Macro Impact & AI Powered Market Entry Ideas - BỘ NỘI VỤ
Inotiv, Inc. Earnings Call: Growth Amid Challenges - TipRanks
CEO Change: Why Inotiv Inc stock is in analyst buy zoneStock Surge & Consistent Growth Stock Picks - moha.gov.vn
Inotiv, Inc. SEC 10-K Report - TradingView — Track All Markets
Inotiv, Inc. (NASDAQ:NOTV) Q4 2025 Earnings Call Transcript - Insider Monkey
Will Inotiv Inc. (BS50) stock outperform foreign stocksQuarterly Earnings Report & Safe Capital Growth Stock Tips - Newser
Pharma firm Inotiv discloses data breach after ransomware attack - BleepingComputer
Is Inotiv Inc. stock a defensive play in 20252025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Will Inotiv Inc. (BS50) stock gain from green policies2025 Volume Leaders & Real-Time Volume Analysis - Newser
Inotiv Inc (NOTV) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Cybersecurity Challenges By GuruFocus - Investing.com Canada
Lake Street Maintains Inotiv (NOTV) Buy Recommendation - Nasdaq
Why Inotiv Inc. stock is a must watch in 2025Quarterly Profit Summary & Real-Time Buy Zone Alerts - Newser
Inotiv (NOTV) Analyst Rating Update: Price Target Lowered by Lak - GuruFocus
Why Inotiv Inc. stock is in analyst buy zone2025 Market Outlook & Daily Profit Maximizing Trade Tips - Newser
How big funds are accumulating Inotiv Inc. (BS50) stockJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update - The Manila Times
How forex fluctuations impact Inotiv Inc. (BS50) stockJuly 2025 Review & Entry Point Confirmation Signals - Newser
Inotiv Says Personal Information Stolen in Ransomware Attack - SecurityWeek
Inotiv, Inc. Reports Improved Fiscal 2025 Results - TipRanks
Earnings call transcript: Inotiv reports Q4 2025 earnings beat, stock surges By Investing.com - Investing.com India
Earnings call transcript: Inotiv reports Q4 2025 earnings beat, stock surges - Investing.com
Inotiv Inc Stock (NOTV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):